Assessing PFAS Exposure (APEX) for Better Health
APEX
Reducing Rural Health Disparities by Empowering People to Minimize PFAS Exposure and Improve Cardiovascular Health
2 other identifiers
interventional
110
1 country
1
Brief Summary
The goal of this observational study is to determine whether a personalized PFAS (per- and polyfluoroalkyl substances) blood test and educational report-back can improve environmental health literacy (EHL), empower exposure reduction behaviors, and promote cardiovascular wellness among rural adults. The main questions it aims to answer are: Does receiving a personalized PFAS test result and educational report-back increase environmental health literacy among rural participants and healthcare providers? Does increased EHL lead to greater readiness and actions to reduce PFAS exposure and improve wellness outcomes (e.g., reduced stress, improved sleep, increased sense of control) Researchers will compare changes from pre- to post-intervention among participants who receive the personalized PFAS report-back to see if there are measurable improvements in knowledge, behavior, and wellbeing. Participants will: Provide a mail-in blood spot sample for PFAS testing using a validated laboratory method (Relentless Health). Complete online surveys before and after receiving results to assess PFAS knowledge, exposure behaviors, and wellness outcomes. Receive a personalized PFAS report-back summarizing individual results, exposure sources, and tailored strategies for exposure reduction. Participate in focus groups or interviews (subset only) to provide feedback on report clarity, usability, and communication preferences. This study focuses on rural adult residents of Nevada, including underserved populations who may face limited access to PFAS testing or environmental health education. Insights from this Phase I project will guide a future randomized controlled trial evaluating the intervention's broader impact on cardiovascular health and rural health equity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2025
CompletedFirst Submitted
Initial submission to the registry
December 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2026
CompletedFirst Posted
Study publicly available on registry
February 5, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2026
CompletedFebruary 5, 2026
January 1, 2026
5 months
December 1, 2025
January 29, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in PFAS Environmental Health Literacy
Change in PFAS-specific environmental health literacy (pre- vs post-intervention). Participants complete a 12 question survey with Likert type response options. Three subscales (4 questions each for knowledge, attitudes, and behavior) are summed separately, each with a minimum value of 4 and a maximum of 20. A higher score is considered better.
4 weeks
Change in response to a survey question assessing "Readiness to reduce PFAS exposure"
Participants are asked to choose the sentence (from among 5 options) that most accurately describes their current efforts and interest in limiting their exposure to PFAS. Each sentence reflects one of 5 stages of change, in order from earlier to later (better): precontemplation, contemplation, preparation, action, and maintenance. The post-intervention stage is compared to the pre-intervention stage to identify increased, decreased, or no change in readiness to reduce PFAS exposure after completing the intervention.
4 weeks
Secondary Outcomes (2)
Usability, clarity, and satisfaction with the report-back materials
4 weeks
Identification of challenges to behavioral change
4 weeks
Study Arms (1)
All Participants
OTHERAll participants who take the PFAS Blood Test
Interventions
Participants take an at home blood test to test their PFAS levels and receive a report back with recommendations to reduce exposures.
Eligibility Criteria
You may qualify if:
- Age ≥ 18 years
- Residing or working in a rural area (verified via zip code and Health Resources and Services Administration classification)
- Ability to understand English and complete study activities
- Willingness to provide mail-in blood sample and complete pre- and post-surveys
You may not qualify if:
- Age\<18
- Residing in an urban or suburban area
- Does not understand English or complete study activities
- Not willing to provide a mail-in blood sample and/or complete pre- and post- surveys
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- National Heart, Lung, and Blood Institute (NHLBI)collaborator
- Million Marker Wellness, Inc.lead
- Renown Healthcollaborator
Study Sites (1)
Million Marker
Berkeley, California, 94704, United States
Related Publications (19)
Carignan CC, Bauer RA, Patterson A, Phomsopha T, Redman E, Stapleton HM, Higgins CP. Self-Collection Blood Test for PFASs: Comparing Volumetric Microsamplers with a Traditional Serum Approach. Environ Sci Technol. 2023 May 30;57(21):7950-7957. doi: 10.1021/acs.est.2c09852. Epub 2023 May 15.
PMID: 37189231BACKGROUNDRochester JR, Kwiatkowski CF, Neveux I, Dabe S, Hatcher KM, Lathrop MK, Daza EJ, Eskenazi B, Grzymski JJ, Hua J. A Personalized Intervention to Increase Environmental Health Literacy and Readiness to Change in a Northern Nevada Population: Effects of Environmental Chemical Exposure Report-Back. Int J Environ Res Public Health. 2024 Jul 11;21(7):905. doi: 10.3390/ijerph21070905.
PMID: 39063482BACKGROUNDBoronow KE, Cohn B, Havas L, Plumb M, Brody JG. The Effect of Individual or Study-Wide Report-Back on Knowledge, Concern, and Exposure-Reducing Behaviors Related to Endocrine-Disrupting Chemicals. Environ Health Perspect. 2023 Sep;131(9):97005. doi: 10.1289/EHP12565. Epub 2023 Sep 8.
PMID: 37682721BACKGROUNDKorfmacher KS, Brody JG. Moving Forward with Reporting Back Individual Environmental Health Research Results. Environ Health Perspect. 2023 Dec;131(12):125002. doi: 10.1289/EHP12463. Epub 2023 Dec 14.
PMID: 38095662BACKGROUNDGehle KS, Crawford JL, Hatcher MT. Integrating environmental health into medical education. Am J Prev Med. 2011 Oct;41(4 Suppl 3):S296-301. doi: 10.1016/j.amepre.2011.06.007.
PMID: 21961679BACKGROUNDFinn S, O'Fallon L. The Emergence of Environmental Health Literacy-From Its Roots to Its Future Potential. Environ Health Perspect. 2017 Apr;125(4):495-501. doi: 10.1289/ehp.1409337. Epub 2015 Jun 30.
PMID: 26126293BACKGROUNDJohnston J, Cushing L. Chemical Exposures, Health, and Environmental Justice in Communities Living on the Fenceline of Industry. Curr Environ Health Rep. 2020 Mar;7(1):48-57. doi: 10.1007/s40572-020-00263-8.
PMID: 31970715BACKGROUNDBullard RD, Wright BH. Environmental justice for all: community perspectives on health and research needs. Toxicol Ind Health. 1993 Sep-Oct;9(5):821-41. doi: 10.1177/074823379300900508.
PMID: 8184445BACKGROUNDHill-Briggs F, Ephraim PL, Vrany EA, Davidson KW, Pekmezaris R, Salas-Lopez D, Alfano CM, Gary-Webb TL. Social Determinants of Health, Race, and Diabetes Population Health Improvement: Black/African Americans as a Population Exemplar. Curr Diab Rep. 2022 Mar;22(3):117-128. doi: 10.1007/s11892-022-01454-3. Epub 2022 Mar 3.
PMID: 35239086BACKGROUNDUnited States Environmental Protection Agency. Biden-Harris Administration Finalizes First-Ever National Drinking Water Standard to Protect 100M People from PFAS Pollution. https://www.epa.gov/newsreleases/biden-harris-administration-finalizes-first-ever-national-drinking-water-standard (accessed 2024-06-05).
BACKGROUNDC8 Science Panel. C8 Probable Link Reports. C8 Science Panel. http://c8sciencepanel.org/prob_link.html (accessed 2024-06-05).
BACKGROUNDFenton SE, Ducatman A, Boobis A, DeWitt JC, Lau C, Ng C, Smith JS, Roberts SM. Per- and Polyfluoroalkyl Substance Toxicity and Human Health Review: Current State of Knowledge and Strategies for Informing Future Research. Environ Toxicol Chem. 2021 Mar;40(3):606-630. doi: 10.1002/etc.4890. Epub 2020 Dec 7.
PMID: 33017053BACKGROUNDBlake BE, Fenton SE. Early life exposure to per- and polyfluoroalkyl substances (PFAS) and latent health outcomes: A review including the placenta as a target tissue and possible driver of peri- and postnatal effects. Toxicology. 2020 Oct;443:152565. doi: 10.1016/j.tox.2020.152565. Epub 2020 Aug 27.
PMID: 32861749BACKGROUNDNational Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Division on Earth and Life Studies; Board on Population Health and Public Health Practice; Board on Environmental Studies and Toxicology; Committee on the Guidance on PFAS Testing and Health Outcomes. Guidance on PFAS Exposure, Testing, and Clinical Follow-Up. Washington (DC): National Academies Press (US); 2022 Jul 28. Available from http://www.ncbi.nlm.nih.gov/books/NBK582439/
PMID: 35939564BACKGROUNDWen ZJ, Wei YJ, Zhang YF, Zhang YF. A review of cardiovascular effects and underlying mechanisms of legacy and emerging per- and polyfluoroalkyl substances (PFAS). Arch Toxicol. 2023 May;97(5):1195-1245. doi: 10.1007/s00204-023-03477-5. Epub 2023 Mar 22.
PMID: 36947184BACKGROUNDLiang Y, Zhou H, Zhang J, Li S, Shen W, Lei L. Exposure to perfluoroalkyl and polyfluoroalkyl substances and estimated glomerular filtration rate in adults: a cross-sectional study based on NHANES (2017-2018). Environ Sci Pollut Res Int. 2023 Apr;30(20):57931-57944. doi: 10.1007/s11356-023-26384-9. Epub 2023 Mar 27.
PMID: 36971931BACKGROUNDSunderland EM, Hu XC, Dassuncao C, Tokranov AK, Wagner CC, Allen JG. A review of the pathways of human exposure to poly- and perfluoroalkyl substances (PFASs) and present understanding of health effects. J Expo Sci Environ Epidemiol. 2019 Mar;29(2):131-147. doi: 10.1038/s41370-018-0094-1. Epub 2018 Nov 23.
PMID: 30470793BACKGROUNDCousins IT, Johansson JH, Salter ME, Sha B, Scheringer M. Outside the Safe Operating Space of a New Planetary Boundary for Per- and Polyfluoroalkyl Substances (PFAS). Environ Sci Technol. 2022 Aug 16;56(16):11172-11179. doi: 10.1021/acs.est.2c02765. Epub 2022 Aug 2.
PMID: 35916421BACKGROUNDGluge J , Scheringer M , Cousins IT , DeWitt JC , Goldenman G , Herzke D , Lohmann R , Ng CA , Trier X , Wang Z . An overview of the uses of per- and polyfluoroalkyl substances (PFAS). Environ Sci Process Impacts. 2020 Dec 1;22(12):2345-2373. doi: 10.1039/d0em00291g. Epub 2020 Oct 30.
PMID: 33125022BACKGROUND
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Carol Kwiatkowski
Million Marker Wellness
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Environmental Health Scientist
Study Record Dates
First Submitted
December 1, 2025
First Posted
February 5, 2026
Study Start
September 1, 2025
Primary Completion
January 31, 2026
Study Completion
February 28, 2026
Last Updated
February 5, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- Starting six months after publication
- Access Criteria
- Researchers must submit an acceptable research plan (goals of the proposed research, the specific hypotheses to be examined, justification for research and methods), be affiliated with a recognized research institution, have demonstrated expertise in the area of the proposed research project, and receive independent approval from their governing institutional review board. Data will be available for use only to answer the specific question(s) indicated in the research plan. The researchers must provide a list of variable names and an outline of how research findings will be disseminated; and will be asked to sign a data-sharing agreement that commits to: 1) not attempt to identify any individual participant, 2) secure the data using appropriate software technology, 3) and destroy or return all data once analyses are complete. All final datasets will be de-identified. Final authorship on manuscripts will require review and approval by the Principal Investigators of this study.
Million Marker will disseminate research results and findings to the scientific community through presentations at scientific meetings and conferences and publications in academic journals, as well as through the mass media and online postings. The Principal Investigator of this study will make data and associated documentation/metadata available to external researchers under a data-sharing agreement in which a specific commitment is made to use the data for research purposes only, to not provide the data to a third party or distribute it in any form, and to properly acknowledge the source of funding for the collection of the data and the researchers involved in this study.